Expression of galectin-3 in gastric adenocarcinoma

Indian Journal of Medical Research

Volumn 140, Issue JUL, 2014, Pages 69-76

  Gomes, Thiago Simão ^a   Oshima, Celina Tizuko Fujiyama ^a   Forones, Nora Manoukian ^a   De Oliveira Lima, Flávio ^a   Ribeiro, Daniel Araki ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biomarker; Galectin 3; Gastric adenocarcinoma; Immunoexpression; Prognosis

Indexed keywords

GALECTIN 3;

ADENOCARCINOMA; BRAZIL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; BRAZIL; FEMALE; GALECTIN 3; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; STOMACH NEOPLASMS;

EID: 84906890946     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Herszenyi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 2010; 14: 249-58.
2. INCA Instituto Nacional de Cancer, Brazil. Available from: http://www.inca.gov.br, acessed on June 25, 2014.
3. Barondes SH, Cooper DN, Gitt MA, Leffler H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994; 269: 20807-10.
4. Jia S, Wang JL. Carbohydrate binding protein 35. Complementary DNA sequence reveals homology with proteins of the heterogeneous nuclear RNP J Biol Chem 1988; 263: 6009-11.
5. Woo HJ, Shaw LM, Messier JM, Mercurio AM. The major non-integrin laminin binding protein of macrophages is identical to carbohydrate binding protein 35 (Mac-2). J Biol Chem 1990; 265: 7097-9.
6. Robertson MW, Albrandt K, Keller D, Liu FT. Human IgE- binding protein: a soluble lectin exhibiting a highly conserved interspecies sequence and differential recognition of IgE glycoforms. Biochemistry 1990; 29: 8093-100.
7. Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1999; 1473: 172-85.
8. Truong MJ, Gruart V, Kusnierz JP, Papin JP, Loiseau S, Capron A, et al. Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation. J Exp Med 1993; 177: 243-8.
9. Frigeri LG, Liu FT. Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J Immunol 1992; 148: 861-7.
10. Bieber T. IgE-binding molecules on human Langerhans cells. Acta Derm Venereol Suppl (Stockh). 1992; 176:54-7.
11. Ochieng J, Furtak V, Lukyanov P. Extracellular functions of galectin-3. Glycoconj J2004; 19: 527-35.
12. Takenaka Y, Fukumori T, Yoshii T, Oka N, Inohara H, Kim HR, et al. Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol 2004; 24: 4395-406.
13. Castronovo V, Luyten F, van den Brule F, Sobel ME. Identification of a 14-kDa laminin binding protein (HLBP14) in human melanoma cells that is identical to the 14-kDa galactoside binding lectin. Arch Biochem Biophys 1992; 297: 132-8.
14. Miyazaki J, Hokari R, Kato S, Tsuzuki Y, Kawaguchi A, Nagao S, et al. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes. Oncol Rep 2002; 9: 1307-12.
15. Okada K, Shimura T, Suehiro T, Mochiki E, Kuwano H. Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer. Anticancer Res 2006; 26: 1369-76.
16. Arfaoui-Toumi A, Kria-Ben Mahmoud L, Ben Hmida M, Khalfallah MT, Regaya-Mzabi S, Bouraoui S. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients). Bull Cancer 2010; 97: E1-8.
17. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer 2005; 5: 29-41.
18. Raimond J, Rouleux F, Monsigny M, Legrand A. The second intron of the human galectin-3 gene has a strong promoter activity down-regulated by p53. FEBS Lett 1995; 363: 165-9.
19. Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, Nakatani Y, et al. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 1999; 15: 143-8.
20. Califice S, Castronovo V, Bracke M, van den Brule F. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene 2004; 23: 7527-36.
21. van den Brule FA, Waltregny D, Liu FT, Castronovo V. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer 2000; 89: 361-7.
22. Baldus SE, Zirbes TK, Weingarten M, Fromm S, Glossmann J, Hanisch FG, et al. Increased galectin-3 expression in gastric cancer: correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation. Tumour Biol 2000; 21: 258-66.
23. Yoshii T, Inohara H, Takenaka Y, Honjo Y, Akahanis, Nomura T, et al. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Int J Oncol 2001; 18: 787-92.
24. Dong WG, Yu QF, Xu Y, Fan LF, Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer. Dig Dis Sci 2008; 53: 1811-7.
25. Nakahara S, Raz A. Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway. Cancer Metastasis Rev 2007; 26: 605-10.
26. Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. clin cancer Res 2000; 6: 4635-40.
27. Lotan R, Ito H, Yasui W, Yokozaki H, Lotan D, Tahara E. Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas. In J cancer 1994; 56: 474-80.